Nifty

:

22795.90

Sensex

:

75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Login

Nifty
Sensex

:
:

22795.90
75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Vaishali Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: Not Listed | NSE: VAISHALI

Watchlist

NSE BSE

16.95

06-Feb-2025

Open
High
Low
Previous Close

17.00
17.80
16.72
16.97

Volume
Traded Value (lacs)
52 Week High
52 Week Low

416545
72.11
24.91
12.49

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

199.35
470.16
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

210.55
N/A
3.54

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.91
7.50
4.40

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
12.91
-24.66

PAT CAGR (%)

10 Years
5 Years
3 Years

16.23
88.82
-43.63

P:E (Median)

8 Years
5 Years
3 Years

29.32
25.05
27.70

P:BV (Average)

8 Years
5 Years
3 Years

3.15
3.15
4.07

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.44
23.16
28.86

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 27.91 27.89 0.07% 20.79 12.57 65.39% 18.08 13.42 34.72% 32.40 26.24 23.48%
Expenses 26.55 24.94 6.46% 18.37 9.91 85.37% 15.74 11.11 41.67% 39.18 25.46 53.89%
EBITDA 1.37 2.95 -53.56% 2.42 2.66 -9.02% 2.34 2.31 1.30% -6.78 0.78 -
EBIDTM 4.89% 10.58% 11.64% 21.14% 12.96% 17.19% -20.93% 2.97%
Other Income 1.07 0.47 127.66% 0.71 0.30 136.67% 0.42 0.36 16.67% 0.91 0.53 71.70%
Interest 0.38 0.43 -11.63% 0.38 0.47 -19.15% 0.38 0.43 -11.63% 0.40 0.54 -25.93%
Depreciation 0.12 0.12 0.00% 0.12 0.12 0.00% 0.12 0.12 0.00% 0.14 0.15 -6.67%
PBT 1.93 2.86 -32.52% 2.63 2.36 11.44% 2.27 2.12 7.08% -6.42 0.62 -
Tax 0.49 0.75 -34.67% 0.66 0.66 0.00% 0.57 0.53 7.55% -1.73 0.19 -
PAT 1.44 2.11 -31.75% 1.97 1.70 15.88% 1.70 1.59 6.92% -4.68 0.43 -
PATM 5.17% 7.57% 9.46% 13.56% 9.40% 11.82% -14.46% 1.66%
EPS 0.27 0.39 -30.77% 0.37 0.32 15.62% 0.32 0.30 6.67% -0.87 0.08 -

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 99.18 86.28 69.66 75.82 53.77 60.09 75.09 67.76 63.97 66.71 94.56 Net Sales Growth 23.79% 23.86% -8.12% 41.01% -10.52% -19.98% 10.82% 5.92% -4.11% -29.45% Cost Of Goods Sold 87.35 74.42 54.68 63.50 46.15 51.09 68.67 59.90 56.15 62.03 91.25 Gross Profit 11.83 11.86 14.99 12.32 7.62 9.00 6.43 7.86 7.83 4.67 3.31 GP Margin 11.93% 13.75% 21.52% 16.25% 14.17% 14.98% 8.56% 11.60% 12.24% 7.00% 3.50% Total Expenditure 99.84 84.61 60.28 68.94 51.13 59.18 73.01 64.97 60.50 66.16 94.85 Power & Fuel Cost - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Employee Cost - 1.40 1.30 1.36 1.19 1.27 2.13 2.04 1.59 1.56 1.85 % Of Sales - 1.62% 1.87% 1.79% 2.21% 2.11% 2.84% 3.01% 2.49% 2.34% 1.96% Manufacturing Exp. - 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.00 0.00 % Of Sales - 0.02% 0.03% 0.03% 0.04% 0.03% 0.04% 0.04% 0.05% 0% 0% General & Admin Exp. - 2.00 1.59 1.38 1.20 1.54 1.08 1.67 1.51 2.57 1.75 % Of Sales - 2.32% 2.28% 1.82% 2.23% 2.56% 1.44% 2.46% 2.36% 3.85% 1.85% Selling & Distn. Exp. - 1.41 2.69 2.67 0.74 1.07 1.07 1.32 1.19 0.00 0.00 % Of Sales - 1.63% 3.86% 3.52% 1.38% 1.78% 1.42% 1.95% 1.86% 0% 0% Miscellaneous Exp. - 5.35 0.00 0.00 1.82 4.19 0.04 0.01 0.03 0.00 0.00 % Of Sales - 6.20% 0% 0% 3.38% 6.97% 0.05% 0.01% 0.05% 0% 0% EBITDA -0.65 1.67 9.38 6.88 2.64 0.91 2.08 2.79 3.47 0.55 -0.29 EBITDA Margin -0.66% 1.94% 13.47% 9.07% 4.91% 1.51% 2.77% 4.12% 5.42% 0.82% -0.31% Other Income 3.11 2.03 2.23 1.79 1.81 2.17 1.98 1.66 0.93 3.18 4.26 Interest 1.54 2.27 2.26 2.49 2.63 2.56 2.66 2.85 3.10 3.37 3.37 Depreciation 0.50 0.51 0.50 0.46 0.43 0.44 0.27 0.25 0.28 0.37 0.45 PBT 0.41 0.93 8.85 5.73 1.40 0.08 1.13 1.35 1.03 0.00 0.15 Tax -0.01 0.21 2.24 1.70 0.36 0.05 0.42 0.55 0.32 0.03 -0.01 Tax Rate -2.44% 22.58% 25.31% 29.67% 25.71% 62.50% 37.17% 40.74% 31.07% 0.00% -6.67% PAT 0.43 0.72 6.60 4.02 1.05 0.03 0.71 0.80 0.71 -0.03 0.16 PAT before Minority Interest 0.43 0.72 6.60 4.02 1.05 0.03 0.71 0.80 0.71 -0.03 0.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.43% 0.83% 9.47% 5.30% 1.95% 0.05% 0.95% 1.18% 1.11% -0.04% 0.17% PAT Growth -92.62% -89.09% 64.18% 282.86% 3,400.00% -95.77% -11.25% 12.68% - - EPS 0.08 0.13 1.23 0.75 0.20 0.01 0.13 0.15 0.13 -0.01 0.03

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 42.84 40.53 26.35 22.42 21.38 21.40 20.60 3.97 3.20 3.23 Share Capital 10.72 10.55 10.55 10.55 10.55 6.59 6.59 3.00 0.50 0.50 Total Reserves 25.09 22.43 15.81 11.87 10.84 14.81 14.01 0.97 2.70 2.73 Non-Current Liabilities 3.86 6.15 3.17 4.30 4.28 4.76 2.71 3.44 4.64 8.36 Secured Loans 4.99 6.32 3.81 5.68 4.75 5.36 0.97 1.07 0.00 0.00 Unsecured Loans -1.39 -1.09 -0.70 -1.64 -0.70 -0.58 1.68 2.31 4.48 8.22 Long Term Provisions 0.20 0.19 0.19 0.18 0.14 0.09 0.18 0.20 0.00 0.00 Current Liabilities 33.08 32.07 51.94 59.26 40.42 42.48 40.79 37.32 41.55 34.20 Trade Payables 19.39 18.00 28.38 40.54 23.63 24.53 22.38 15.38 24.66 17.17 Other Current Liabilities 6.05 4.76 5.56 6.71 5.08 5.76 3.11 3.80 1.30 1.04 Short Term Borrowings 7.62 7.34 16.69 11.62 11.63 11.45 14.91 17.75 15.29 15.83 Short Term Provisions 0.03 1.97 1.31 0.39 0.08 0.74 0.39 0.39 0.31 0.16 Total Liabilities 79.78 78.75 81.46 85.98 66.08 68.64 64.10 44.73 49.39 45.79 Net Block 1.52 1.98 1.18 1.22 1.49 1.34 1.26 1.29 1.40 1.68 Gross Block 3.89 3.85 3.30 2.89 2.73 2.14 1.79 1.57 2.51 2.42 Accumulated Depreciation 2.37 1.86 2.12 1.67 1.24 0.80 0.53 0.28 1.11 0.74 Non Current Assets 5.26 6.08 5.03 4.68 4.87 5.67 5.05 4.83 2.15 2.11 Capital Work in Progress 0.74 0.67 0.49 0.05 0.08 0.04 0.08 0.00 0.00 0.00 Non Current Investment 0.43 0.43 0.43 0.43 0.43 0.43 0.43 0.38 0.38 0.38 Long Term Loans & Adv. 0.93 1.43 1.43 0.96 0.93 0.89 0.84 0.88 0.38 0.06 Other Non Current Assets 1.64 1.56 1.50 2.03 1.94 2.98 2.44 2.28 0.00 0.00 Current Assets 74.52 72.67 76.43 81.30 61.21 62.97 59.05 39.91 47.25 43.69 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.38 3.05 0.63 0.59 0.88 0.98 1.87 1.15 3.36 3.32 Sundry Debtors 49.43 53.61 58.51 66.73 47.03 49.42 44.58 37.47 40.42 34.36 Cash & Bank 1.58 0.98 1.36 0.47 0.38 0.32 0.28 0.18 1.05 1.01 Other Current Assets 23.13 0.43 0.39 0.49 12.92 12.25 12.32 1.10 2.43 4.99 Short Term Loans & Adv. 22.66 14.60 15.55 13.02 12.69 11.77 11.75 0.48 0.90 1.95 Net Current Assets 41.44 40.60 24.49 22.03 20.79 20.49 18.26 2.58 5.70 9.48 Total Assets 79.78 78.75 81.46 85.98 66.08 68.64 64.10 44.74 49.40 45.80

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 0.81 1.08 1.32 2.01 3.22 4.31 -9.46 0.46 4.59 -3.72 PBT 0.93 8.85 5.73 1.40 0.08 1.13 1.35 1.03 0.00 0.15 Adjustment 5.85 1.16 1.62 3.45 5.78 1.66 1.61 2.45 0.55 0.31 Changes in Working Capital -3.70 -7.36 -5.20 -2.78 -1.91 1.62 -12.04 -2.95 4.08 -4.08 Cash after chg. in Working capital 3.08 2.64 2.15 2.07 3.94 4.41 -9.09 0.54 4.63 -3.62 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.28 -1.56 -0.83 -0.06 -0.72 -0.10 -0.37 -0.08 -0.04 -0.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 1.20 0.28 -0.85 -0.11 -0.02 -0.28 1.06 0.69 3.07 1.78 Net Fixed Assets -0.11 -0.73 -0.85 -0.13 -0.63 -0.31 -0.30 0.94 -0.09 -1.52 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 -0.05 0.00 0.00 -0.21 Others 1.31 1.01 0.00 0.02 0.61 0.03 1.41 -0.25 3.16 3.51 Cash from Financing Activity -1.42 -1.73 0.42 -1.81 -3.14 -3.99 8.50 -1.20 -7.62 1.93 Net Cash Inflow / Outflow 0.59 -0.37 0.89 0.09 0.06 0.04 0.10 -0.05 0.04 0.00 Opening Cash & Equivalents 0.98 1.36 0.47 0.38 0.32 0.28 0.18 0.23 1.01 1.01 Closing Cash & Equivalent 1.58 0.98 1.36 0.47 0.38 0.32 0.28 0.18 1.05 1.01

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 3.34 3.13 24.99 21.26 20.27 20.29 19.53 8.28 40.06 40.44 ROA 0.91% 8.24% 4.81% 1.38% 0.05% 1.08% 1.47% 1.51% -0.06% 0.33% ROE 2.09% 22.26% 16.50% 4.78% 0.15% 3.40% 6.49% 19.80% -0.94% 5.12% ROCE 5.82% 21.92% 18.87% 10.33% 6.89% 9.80% 12.75% 16.18% 12.80% 14.04% Fixed Asset Turnover 22.31 19.49 24.50 19.16 24.69 38.19 40.34 31.42 27.08 63.93 Receivable days 217.95 293.72 301.44 386.08 292.96 228.47 220.99 222.20 204.58 140.04 Inventory Days 7.25 9.64 2.93 4.98 5.65 6.92 8.14 12.88 18.27 22.13 Payable days 91.69 154.80 198.07 253.76 172.05 120.07 107.14 127.98 119.29 99.29 Cash Conversion Cycle 133.52 148.56 106.30 137.31 126.57 115.32 121.99 107.11 103.57 62.87 Total Debt/Equity 0.35 0.41 0.79 0.78 0.78 0.80 0.89 5.75 6.56 7.75 Interest Cover 1.41 4.92 3.30 1.53 1.03 1.43 1.47 1.33 1.00 1.05

Top Investors:

sapan anil shah

nupur anil shah

sawaca business machines limited

krishna awtar kabra

Annual Reports:

News Update:

Vaishali Pharma - Quarterly Results
6th Feb 2025, 17:39 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback